- Home
- SMSI vs BIVI Comparison
SMSI vs BIVI Comparison
Compare SMSI & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- BIVI
- Stock Information
- Founded
- SMSI 1982
- BIVI 2013
- Country
- SMSI United States
- BIVI United States
- Employees
- SMSI N/A
- BIVI N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- BIVI Health Care
- Exchange
- SMSI Nasdaq
- BIVI Nasdaq
- Market Cap
- SMSI 15.9M
- BIVI 18.6M
- IPO Year
- SMSI 1995
- BIVI N/A
- Fundamental
- Price
- SMSI $0.89
- BIVI $0.97
- Analyst Decision
- SMSI Strong Buy
- BIVI
- Analyst Count
- SMSI 1
- BIVI 0
- Target Price
- SMSI $5.00
- BIVI N/A
- AVG Volume (30 Days)
- SMSI 104.0K
- BIVI 210.2K
- Earning Date
- SMSI 07-31-2025
- BIVI 05-12-2025
- Dividend Yield
- SMSI N/A
- BIVI N/A
- EPS Growth
- SMSI N/A
- BIVI N/A
- EPS
- SMSI N/A
- BIVI N/A
- Revenue
- SMSI $19,378,000.00
- BIVI N/A
- Revenue This Year
- SMSI $10.12
- BIVI N/A
- Revenue Next Year
- SMSI $63.12
- BIVI N/A
- P/E Ratio
- SMSI N/A
- BIVI N/A
- Revenue Growth
- SMSI N/A
- BIVI N/A
- 52 Week Low
- SMSI $0.52
- BIVI $0.62
- 52 Week High
- SMSI $2.57
- BIVI $7.50
- Technical
- Relative Strength Index (RSI)
- SMSI 51.78
- BIVI 42.25
- Support Level
- SMSI $0.84
- BIVI $0.88
- Resistance Level
- SMSI $0.98
- BIVI $1.03
- Average True Range (ATR)
- SMSI 0.06
- BIVI 0.07
- MACD
- SMSI -0.00
- BIVI -0.02
- Stochastic Oscillator
- SMSI 43.75
- BIVI 23.97
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.